Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.11 USD | +0.48% | -3.70% | +1.13% |
06/05 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
06/05 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.13% | 264.37Cr | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+43.62% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics : HC Wainwright Adjusts Celldex Therapeutics PT to $60 From $54, Maintains Buy Rating